Abstract:The increasing mortality rate of pancreatic cancer globally necessitates the urgent identification for novel therapeutic targets. This study investigated the expression, functions, and mechanistic insight of G protein inhibitory subunit 3 (Gαi3) in pancreatic cancer. Bioinformatics analyses reveal that Gαi3 is overexpressed in human pancreatic cancer, correlating with poor prognosis, higher tumor grade, and advanced classification. Elevated Gαi3 levels are also confirmed in human pancreatic cancer tissues and primary/immortalized cancer cells. Gαi3 shRNA or knockout (KO) significantly reduced cell viability, proliferation, cell cycle progression, and mobility in primary/immortalized pancreatic cancer cells. Conversely, Gαi3 overexpression enhanced pancreatic cancer cell growth. RNA-sequencing and bioinformatics analyses of Gαi3-depleted cells indicated Gαi3's role in modulating the Akt-mTOR and PKA-Hippo-YAP pathways. Akt-S6 phosphorylation was decreased in Gαi3-depleted cells, but was increased with Gαi3 overexpression. Additionally, Gαi3 depletion elevated PKA activity and activated the Hippo pathway kinase LATS1/2, leading to YAP/TAZ inactivation, while Gαi3 overexpression exerted the opposite effects. There is an increased binding between Gαi3 promoter and the transcription factor TCF7L2 in pancreatic cancer tissues and cells. Gαi3 expression was significantly decreased following TCF7L2 silencing, but increased with TCF7L2 overexpression. In vivo, intratumoral injection of Gαi3 shRNA-expressing adeno-associated virus significantly inhibited subcutaneous pancreatic cancer xenografts growth in nude mice. A significant growth reduction was also observed in xenografts from Gαi3 knockout pancreatic cancer cells. Akt-mTOR inactivation and increased PKA activity coupled with YAP/TAZ inactivation were also detected in xenograft tumors upon Gαi3 depletion. Furthermore, bioinformatic analysis and multiplex immunohistochemistry (mIHC) staining on pancreatic cancer tissue microarrays showed a reduced proportion of M1-type macrophages and an increase in PD-L1 positive cells in Gαi3-high pancreatic cancer tissues. Collectively, these findings highlight Gαi3's critical role in promoting pancreatic cancer cell growth, potentially through the modulation of the Akt-mTOR and PKA-Hippo-YAP pathways and its influence on the immune landscape.

Shrna Silencing Glycogen Synthase Kinase-3 Beta Inhibits Tumor Growth and Angiogenesis in Pancreatic Cancer

Neuropilin-2–Mediated Tumor Growth and Angiogenesis in Pancreatic Adenocarcinoma

The Virus-Induced Protein APOBEC3G Inhibits Anoikis by Activation of Akt Kinase in Pancreatic Cancer Cells.

Glycogen synthase kinase-3β: a novel therapeutic target for pancreatic cancer

In-vitro Study of Glycogen Synthase Kinase-3Β on Regulation of Migration, Invasion and Epithelial-Mesenchymal Transition in Pancreatic Cancer Cells

Glycogen Synthase Kinase 3β in Pancreatic Cancer and Its Implications in Chemotherapy and Radiation Therapy.

GSK-3β Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and Nutraceuticals

GSK-3β in Pancreatic Cancer: Spotlight on 9-ING-41, Its Therapeutic Potential and Immune Modulatory Properties

GSK-3 beta regulates tumor growth and angiogenesis in human glioma cells

Effects of Glycogen Synthase Kinase3β Silencing on Cell Growth and Epithelial-Mesenchymal Transition in Pancreatic Cancer PANC1 Cells

GSK3β Overexpression Indicates Poor Prognosis and Its Inhibition Reduces Cell Proliferation and Survival of Non-Small Cell Lung Cancer Cells

Glycogen Synthase Kinase 3 Beta Induces Apoptosis In Cancer Cells Through Increase Of Survivin Nuclear Localization

YY1 Targets Tubulin Polymerisation-Promoting Protein to Inhibit Migration, Invasion and Angiogenesis in Pancreatic Cancer Via P38/mapk and PI3K/AKT Pathways

Glycogen Synthase Kinase 3 Beta In Tumorigenesis And Oncotherapy

STAT3-targeting RNA Interference Inhibits Pancreatic Cancer Angiogenesis in Vitro and in Vivo

Inhibition of GSK-3β Activity Suppresses HCC Malignant Phenotype by Inhibiting Glycolysis Via Activating AMPK/mTOR Signaling.

Glycogen Synthase Kinase-3 and Tumorigenesis

Glycogen Synthase Kinase 3β Induces Apoptosis in Lung Cancer Cells Through Modulating Survivin Expression

Evaluation of the effect of GSK-3β on liver cancer based on the PI3K/AKT pathway

Identification of Gαi3 as a promising molecular oncotarget of pancreatic cancer

Down-regulation of STAT3 Expression by Vector-Based Small Interfering RNA Inhibits Pancreatic Cancer Growth